SEC Form 4 · accession 0001410578-18-000585
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carsten Brunn
Officer — President and CEO · Director
Period of report
Dec 1, 2018
Accepted (ET)
Dec 3, 2018 · 8:39 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.03 | Dec 1, 2018 | A | 1,000,000 | A | — | Nov 30, 2028 | Common Stock | 1,000,000 | 1,000,000 | D |
| Restricted Stock UnitsF2,F3 | — | Dec 1, 2018 | A | 175,000 | A | — | — | Common Stock | 175,000 | 175,000 | D |
Explanation of responses
- F1This option vests as to 25% on December 1, 2019. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.
- F2Each restricted stock unit represents a contingent right to receive one share of common stock.
- F3This restricted stock unit vests as to 25% on December 1, 2019. The remainder of the units will vest in twelve substantially equal quarterly installments thereafter. The restricted stock units have no expiration date.